Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01703663 · ClinicalTrials.gov registry record · NA
Nasal EPAP for Stroke Patients With Sleep Apnea: a Pilot Trial.
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT01703663 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 40 participants.
The verdict
NCT01703663, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Specific aim: To test the effects of nasal expiratory positive airway pressure (EPAP) therapy on sleep apnea severity among patients with recent ischemic stroke. Hypothesis 1: Ischemic stroke patients with sleep apnea will have less severe sleep apnea, as measured by the apnea-hypopnea index (AHI), with nasal EPAP therapy compared with a control night. Hypothesis 2: Ischemic stroke patients will have higher mean levels of oxygen saturation with nasal EPAP therapy compared with a control night.
Interventions
- DEVICE EPAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2012-11 |
| Est. Completion | 2015-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01703663
The ClinicalTrials.gov registry entry for NCT01703663 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EPAP is the first listed.
NCT01703663 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01703663 about?
NCT01703663 is a clinical study titled "Nasal EPAP for Stroke Patients With Sleep Apnea: a Pilot Trial.". Specific aim: To test the effects of nasal expiratory positive airway pressure (EPAP) therapy on sleep apnea severity among patients with recent ischemic stroke. Hypothesis 1: Ischemic stroke patients with sleep apnea will have less severe sleep apnea, as measured by the apnea-hypopnea index (AHI),...
What is the current status of trial NCT01703663?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2012-11. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01703663?
The interventions under investigation include: EPAP (DEVICE).
Who is sponsoring clinical trial NCT01703663?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.